Surface Pharmaceuticals is a biopharmaceutical company specializing in ocular surface disease. It is focused on development and commercialization of therapeutics for such conditions as dry eye disease. Surface Pharmaceuticals' drug pipeline consists of proprietary drug candidates including eye drops, oral capsules, etc.